Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Portland, Oregon

CNS trials open to children and teens in Portland, OR

8 CNS studies open to children and teens are recruiting participants at sites in Portland as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Portland at a glance

  • 8 studies are recruiting at a site in Portland.
  • By phase: Phase 1/2 (1), Phase 3 (5), Phase 4 (1), No phase (1). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (7), university, hospital or other (1).
  • By research area: Migraine (4), ADHD (3), Epilepsy (1).
  • Most recent update to one of these records: November 6, 2026.

ADHD studies recruiting in Portland

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

    • Phase 3
    • Ages 6 to 11
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT07717879 · updated
  2. Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT07717892 · updated
  3. Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)

    • No phase
    • Ages 6 to 17
    • All sexes
    Sponsor
    Oregon Health and Science University
    Study site
    Oregon Health & Science University
    Registry record
    NCT06133231 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Portland, OR on ClinicalTrials.gov.

Epilepsy studies recruiting in Portland

  1. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    Oregon Health and Science University (OHSU)
    Registry record
    NCT05419492 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Portland, OR on ClinicalTrials.gov.

Migraine studies recruiting in Portland

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Providence Neuroscience Institute - Research Coordinator's Office · Providence St. Vincent Medical Center
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study sites
    Providence Neuroscience Institute: Research Coordinators' Office · Providence Pediatric Specialty Clinic
    Registry record
    NCT04743141 · updated
  3. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Providence Brain and Spine Institute /ID# 231607
    Registry record
    NCT05125302 · updated
  4. Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

    • Phase 4
    • Ages 6 to 11
    • All sexes
    Sponsor
    Upsher-Smith Laboratories
    Study site
    Upsher-Smith Clinical Trial Site #6
    Registry record
    NCT04748601 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Portland, OR on ClinicalTrials.gov.

Ask about studies near Portland

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call